Latest S-1 registration statements

Processa Pharmaceuticals is launching a public offering of common stock and pre-funded warrants to raise capital for its NGC-Cap Phase 2 clinical trial and general corporate purposes.

Infinity Natural Resources, an Appalachian Basin-focused energy company, files an amendment to its S-1 registration statement for an initial public offering (IPO) of Class A common stock.

OneMeta AI amends its share acquisition agreement with Metalanguage Corp. and Saul Leal, issuing additional Series B-1 Convertible Preferred and common shares to Leal.

Adial Pharmaceuticals has filed a registration statement for the resale of up to 5,000,000 shares of its common stock by Alumni Capital LP.

La Rosa Holdings Corp. has filed an amendment to its S-1 registration statement to allow selling stockholders to offer up to 1,460,826 shares of common stock for resale.

Venture Global, Inc., a leading provider of liquefied natural gas, has filed for an initial public offering, seeking to leverage its innovative modular construction approach and significant project pipeline to meet growing global energy demand.

Range Impact Inc. has filed an amended registration statement for the resale of 33,166,670 shares of its common stock by existing shareholders.

EzFill Holdings, Inc. has filed an amendment to its registration statement detailing a public offering of 5,000,000 shares of common stock, the acquisition of NextNRG Holding Corp., and other corporate actions.

Flowco Holdings Inc. files an amendment to its Form S-1 registration statement for its initial public offering.

Nexalin Technology has filed an S-1 registration statement for the resale of up to 2,798,613 shares of common stock by selling stockholders, primarily related to warrants issued in connection with their 2022 public offering.

Ribbon Acquisition Corp, a blank check company, has filed an amendment to its Form S-1 registration statement for a proposed $50 million initial public offering.

Quantum Computing Inc. has filed a registration statement for the resale of up to 8.96 million shares of its common stock by selling stockholders, following recent direct and private placement offerings.

Reshape Lifesciences has entered into an equity purchase agreement with Ascent Partners Fund, providing access to up to $5 million in funding through the sale of common stock.

Apimeds Pharmaceuticals US, Inc. has filed an amendment to its S-1 registration statement for a firm commitment initial public offering of common stock, aiming to raise capital for clinical trials and operations.

Protagenic Therapeutics is registering the resale of 5,844,885 shares of common stock by selling stockholders, including shares issued in a recent private placement and those issuable upon exercise of warrants.

MGO Global Inc. files an amendment to its Form S-1 registration statement to include the Warrant Agency Agreement and the First Amendment to the Business Combination Agreement.

Nuwellis, Inc. has filed an amendment to its S-1 registration statement to allow selling securityholders to resell up to 3,734,511 shares of common stock.

Auddia Inc. has filed a registration statement for the resale of up to 20 million shares of its common stock by White Lion Capital LLC, while also addressing ongoing compliance issues with Nasdaq listing requirements.

Range Impact, Inc. has filed an amended registration statement for the resale of up to 33,166,670 shares of its common stock by existing shareholders.

EzFill Holdings, Inc. has filed an amendment to its registration statement, detailing recent unregistered securities sales, expenses related to the offering, and various agreements.

The Children's Place is launching a rights offering to raise up to $90 million by offering existing shareholders the opportunity to purchase additional shares at a discounted price.

Oragenics, Inc. is launching a public offering of up to 15,151,515 units to raise capital for its ONP-002 concussion treatment and other corporate purposes.

Inseego Corp. has filed a registration statement for the potential resale of up to 5.9 million shares of its common stock by existing stockholders, primarily related to recent debt restructuring transactions.

Translational Development Acquisition Corp., a blank check company, has filed an amendment to its Form S-1 registration statement for a proposed $150 million initial public offering.

MGO Global Inc. is offering up to 2,380,952 units, each consisting of one share of common stock or a pre-funded warrant and one common stock purchase warrant, with an assumed offering price of $2.10 per unit.

Cosmos Health Inc. is offering up to $12 million in common stock, pre-funded warrants, and common warrants in a best-efforts offering.

TEN Holdings, Inc. has filed an amendment to its Form S-1 registration statement for an initial public offering of 2,500,000 shares and a resale offering of up to 4,400,000 shares of common stock.

Cantor Equity Partners I, Inc., a blank check company, has filed Amendment No. 1 to its Form S-1 registration statement for a $200 million initial public offering of Class A ordinary shares.

Quoin Pharmaceuticals is offering up to 19,230,769 ordinary shares represented by American Depositary Shares (ADSs) along with warrants in a reasonable best efforts offering.

Millrose Properties, Inc. files an S-11 form detailing its spin-off from Lennar Corporation and its strategy to provide land acquisition and development financing through its Homesite Option Purchase Platform (HOPPR).